Trials / Completed
CompletedNCT05087693
Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)
Examining the Effect of Salbutamol Use in Asthma and/or Exercise Induced Bronchoconstriction Whilst Exercising in Ozone Air Pollution
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Salbutamol use is increased in areas with high levels of ozone pollution and the potential consequences of this are not well known. The purpose of this study is to examine the effect of salbutamol on lung function and inflammation in people with asthma and/or EIB exercising in ozone air pollution. To examine this, we are planning a randomized cross over trial where people with asthma and/or EIB complete sub maximal exercise in four conditions on four separate days. The four condition are: ozone + salbutamol, filtered air + salbutamol, ozone + placebo medication, and filtered air + placebo medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Salbutamol | Inhaling 200ug of salbutamol |
| DRUG | Placebo medication | Inhaling placebo medication |
| OTHER | Ozone | Breathing 170ppb ozone |
| OTHER | Filtered Air | Breathing filtered air |
| OTHER | Exercise | Cycling at 60% of VO2max on a cycle ergometer |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2023-08-31
- Completion
- 2023-08-31
- First posted
- 2021-10-21
- Last updated
- 2025-03-14
- Results posted
- 2025-03-14
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05087693. Inclusion in this directory is not an endorsement.